• SIMON SAYS, LET’S TALK BUSINESS: David Dodd with GeoVax

  • Jan 19 2023
  • Length: Less than 1 minute
  • Podcast

SIMON SAYS, LET’S TALK BUSINESS: David Dodd with GeoVax By cover art

SIMON SAYS, LET’S TALK BUSINESS: David Dodd with GeoVax

Listen for free

View show details

  • Summary

  • David Dodd/GeoVax GeoVax Labs is a clinical-stage biotechnology company developing novel therapies and vaccines for cancers and many of the world's most threatening infectious diseases. The company's lead program in oncology is a novel oncolytic solid tumor gene-directed therapy, Gedeptin®, presently in a multicenter Phase 1/2 clinical trial for advanced head and neck cancers. GeoVax's […] The post SIMON SAYS, LET’S TALK BUSINESS: David Dodd with GeoVax appeared first on Business RadioX ®.
    Show more Show less
Show more Show less

What listeners say about SIMON SAYS, LET’S TALK BUSINESS: David Dodd with GeoVax

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available